Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ: KNSA · IEX Real-Time Price · USD
26.12
+0.21 (0.81%)
Jul 26, 2024, 4:00 PM EDT - Market closed
Kiniksa Pharmaceuticals Market Cap
Kiniksa Pharmaceuticals has a market cap or net worth of $1.86 billion as of July 26, 2024. Its market cap has increased by 89.05% in one year.
Market Cap
1.86B
Enterprise Value
1.65B
1-Year Change
89.05%
Ranking
Category
Stock Price
$26.12
Market Cap Chart
Since May 24, 2018, Kiniksa Pharmaceuticals's market cap has increased from $914.40M to $1.86B, an increase of 103.05%. That is a compound annual growth rate of 12.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 1.84B | 48.99% |
| Dec 29, 2023 | 1.23B | 18.44% |
| Dec 30, 2022 | 1.04B | 28.47% |
| Dec 31, 2021 | 810.80M | -32.60% |
| Dec 31, 2020 | 1.20B | 98.17% |
| Dec 31, 2019 | 607.00M | -56.32% |
| Dec 31, 2018 | 1.39B | 51.96% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoGenomics | 1.93B |
| Ligand Pharmaceuticals | 1.90B |
| Mirum Pharmaceuticals | 1.90B |
| Harmony Biosciences Holdings | 1.89B |
| Zai Lab | 1.87B |
| Veracyte | 1.82B |
| Keros Therapeutics | 1.81B |
| Galapagos NV | 1.80B |